US Stock MarketDetailed Quotes

Maze Therapeutics (MAZE)

Watchlist
  • 25.680
  • +0.840+3.38%
Close Jun 18 16:00 ET
  • 25.750
  • +0.070+0.27%
Post 16:14 ET
1.42BMarket Cap-10.42P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Maze Therapeutics (MAZE) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-32.51%-39.11M
-247.38%-111.94M
-23.51%-27.73M
-6.19%-24.64M
-120.72%-30.05M
-25.94%-29.52M
187.48%75.95M
-8.76%-22.45M
-16.19%-23.21M
145.05M
Net income from continuing operations
26.16%-24.21M
-351.04%-131.12M
-16.87%-34.57M
-21.55%-30.09M
-124.22%-33.68M
-0.90%-32.79M
152.02%52.23M
-11.30%-29.58M
-0.02%-24.75M
--139.06M
Depreciation and amortization
-35.09%444K
-27.12%2.4M
-29.22%499K
-27.54%571K
-24.00%649K
-28.00%684K
-19.37%3.3M
-27.77%705K
-21.51%788K
--854K
Other non cash items
55.16%1.22M
-23.54%2.65M
-35.60%577K
-49.10%509K
-0.51%779K
-0.25%785K
7.04%3.47M
9.40%896K
43.88%1M
--783K
Change In working capital
-1,561.47%-23.68M
-49.24%-2.27M
-130.16%-311K
109.58%501K
-142.73%-1.04M
-672.29%-1.43M
75.89%-1.52M
145.86%1.03M
-643.30%-5.23M
--2.43M
-Change in receivables
---20M
----
----
----
----
--0
----
----
----
----
-Change in prepaid assets
185.23%404K
-3,262.37%-2.94M
15.10%-433K
-4,953.33%-758K
-157.26%-1.28M
-142.55%-474K
-89.94%93K
59.20%-510K
-101.68%-15K
---496K
-Change in payables and accrued expense
-283.06%-1.85M
-4.11%3.46M
-68.54%838K
160.15%1.73M
-67.20%1.37M
-29.41%-484K
176.77%3.6M
1,302.11%2.66M
-620.47%-2.87M
--4.19M
-Change in other current assets
-278.99%-605K
123.31%537K
148.08%163K
121.92%356K
41.71%-320K
62.50%338K
-6,482.86%-2.3M
36.28%-339K
-1,251.77%-1.62M
---549K
-Change in other current liabilities
-101.37%-1.62M
-14.03%-3.32M
-12.12%-879K
-14.58%-825K
-14.47%-815K
-15.16%-805K
-16.04%-2.92M
-19.51%-784K
-15.38%-720K
---712K
Cash from discontinued investing activities
Operating cash flow
-32.51%-39.11M
-247.38%-111.94M
-23.51%-27.73M
-6.19%-24.64M
-120.72%-30.05M
-25.94%-29.52M
187.48%75.95M
-8.76%-22.45M
-16.19%-23.21M
--145.05M
Investing cash flow
Cash flow from continuing investing activities
2,198.66%6.28M
-14,805.14%-170.96M
-16,988.76%-103.39M
-64,834.95%-66.88M
-145.63%-393K
-7.17%-299K
-160.09%-1.15M
-1,679.41%-605K
-3,533.33%-103K
-160K
Net PPE purchase and sale
68.90%-93K
30.78%-794K
94.38%-34K
33.98%-68K
-145.63%-393K
-7.17%-299K
-160.09%-1.15M
-1,679.41%-605K
-3,533.33%-103K
---160K
Net investment purchase and sale
--6.37M
---170.17M
---103.35M
----
----
--0
--0
--0
----
----
Cash from discontinued investing activities
Investing cash flow
2,198.66%6.28M
-14,805.14%-170.96M
-16,988.76%-103.39M
-64,834.95%-66.88M
-145.63%-393K
-7.17%-299K
-160.09%-1.15M
-1,679.41%-605K
-3,533.33%-103K
---160K
Financing cash flow
Cash flow from continuing financing activities
-66.75%42.36M
196.55%275.34M
-94.89%3.59M
6,786.37%143.76M
297.40%612K
418.20%127.38M
466.66%92.85M
334.04%70.26M
-26,975.00%-2.15M
154K
Net issuance payments of debt
--39.4M
--0
--0
--0
--0
--0
51.30%24.48M
--0
--0
--259K
Net common stock issuance
--0
--270.28M
--163K
--141.75M
--612K
--127.75M
--0
--0
--0
--0
Net preferred stock issuance
----
--0
----
----
----
----
--70.79M
----
----
----
Proceeds from stock option exercised by employees
3,137.30%4.08M
658.80%5.56M
5,339.68%3.43M
788.94%2.01M
--0
-65.48%126K
250.72%733K
425.00%63K
2,725.00%226K
--79K
Net other financing activities
-124.60%-1.12M
84.15%-500K
--0
--0
--0
---500K
---3.15M
---594K
---2.38M
----
Cash from discontinued financing activities
Financing cash flow
-66.75%42.36M
196.55%275.34M
-94.89%3.59M
6,786.37%143.76M
297.40%612K
418.20%127.38M
466.66%92.85M
334.04%70.26M
-26,975.00%-2.15M
--154K
Net cash flow
Beginning cash position
-3.82%190.34M
554.30%197.9M
110.93%317.86M
50.80%265.63M
849.71%295.46M
554.30%197.9M
-70.09%30.25M
333.84%150.7M
222.06%176.15M
--31.11M
Current changes in cash
-90.24%9.52M
-104.51%-7.57M
-370.16%-127.53M
305.17%52.23M
-120.57%-29.83M
11,178.96%97.56M
336.52%167.65M
1,151.57%47.21M
-27.54%-25.46M
--145.04M
End cash Position
-32.36%199.85M
-3.82%190.34M
-3.82%190.34M
110.93%317.86M
50.80%265.63M
849.71%295.46M
554.30%197.9M
554.30%197.9M
333.84%150.7M
--176.15M
Free cash flow
-31.50%-39.21M
-250.70%-112.73M
-20.41%-27.76M
-6.02%-24.71M
-121.01%-30.45M
-25.72%-29.82M
185.72%74.81M
-11.51%-23.06M
-16.72%-23.31M
--144.89M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -32.51%-39.11M-247.38%-111.94M-23.51%-27.73M-6.19%-24.64M-120.72%-30.05M-25.94%-29.52M187.48%75.95M-8.76%-22.45M-16.19%-23.21M145.05M
Net income from continuing operations 26.16%-24.21M-351.04%-131.12M-16.87%-34.57M-21.55%-30.09M-124.22%-33.68M-0.90%-32.79M152.02%52.23M-11.30%-29.58M-0.02%-24.75M--139.06M
Depreciation and amortization -35.09%444K-27.12%2.4M-29.22%499K-27.54%571K-24.00%649K-28.00%684K-19.37%3.3M-27.77%705K-21.51%788K--854K
Other non cash items 55.16%1.22M-23.54%2.65M-35.60%577K-49.10%509K-0.51%779K-0.25%785K7.04%3.47M9.40%896K43.88%1M--783K
Change In working capital -1,561.47%-23.68M-49.24%-2.27M-130.16%-311K109.58%501K-142.73%-1.04M-672.29%-1.43M75.89%-1.52M145.86%1.03M-643.30%-5.23M--2.43M
-Change in receivables ---20M------------------0----------------
-Change in prepaid assets 185.23%404K-3,262.37%-2.94M15.10%-433K-4,953.33%-758K-157.26%-1.28M-142.55%-474K-89.94%93K59.20%-510K-101.68%-15K---496K
-Change in payables and accrued expense -283.06%-1.85M-4.11%3.46M-68.54%838K160.15%1.73M-67.20%1.37M-29.41%-484K176.77%3.6M1,302.11%2.66M-620.47%-2.87M--4.19M
-Change in other current assets -278.99%-605K123.31%537K148.08%163K121.92%356K41.71%-320K62.50%338K-6,482.86%-2.3M36.28%-339K-1,251.77%-1.62M---549K
-Change in other current liabilities -101.37%-1.62M-14.03%-3.32M-12.12%-879K-14.58%-825K-14.47%-815K-15.16%-805K-16.04%-2.92M-19.51%-784K-15.38%-720K---712K
Cash from discontinued investing activities
Operating cash flow -32.51%-39.11M-247.38%-111.94M-23.51%-27.73M-6.19%-24.64M-120.72%-30.05M-25.94%-29.52M187.48%75.95M-8.76%-22.45M-16.19%-23.21M--145.05M
Investing cash flow
Cash flow from continuing investing activities 2,198.66%6.28M-14,805.14%-170.96M-16,988.76%-103.39M-64,834.95%-66.88M-145.63%-393K-7.17%-299K-160.09%-1.15M-1,679.41%-605K-3,533.33%-103K-160K
Net PPE purchase and sale 68.90%-93K30.78%-794K94.38%-34K33.98%-68K-145.63%-393K-7.17%-299K-160.09%-1.15M-1,679.41%-605K-3,533.33%-103K---160K
Net investment purchase and sale --6.37M---170.17M---103.35M----------0--0--0--------
Cash from discontinued investing activities
Investing cash flow 2,198.66%6.28M-14,805.14%-170.96M-16,988.76%-103.39M-64,834.95%-66.88M-145.63%-393K-7.17%-299K-160.09%-1.15M-1,679.41%-605K-3,533.33%-103K---160K
Financing cash flow
Cash flow from continuing financing activities -66.75%42.36M196.55%275.34M-94.89%3.59M6,786.37%143.76M297.40%612K418.20%127.38M466.66%92.85M334.04%70.26M-26,975.00%-2.15M154K
Net issuance payments of debt --39.4M--0--0--0--0--051.30%24.48M--0--0--259K
Net common stock issuance --0--270.28M--163K--141.75M--612K--127.75M--0--0--0--0
Net preferred stock issuance ------0------------------70.79M------------
Proceeds from stock option exercised by employees 3,137.30%4.08M658.80%5.56M5,339.68%3.43M788.94%2.01M--0-65.48%126K250.72%733K425.00%63K2,725.00%226K--79K
Net other financing activities -124.60%-1.12M84.15%-500K--0--0--0---500K---3.15M---594K---2.38M----
Cash from discontinued financing activities
Financing cash flow -66.75%42.36M196.55%275.34M-94.89%3.59M6,786.37%143.76M297.40%612K418.20%127.38M466.66%92.85M334.04%70.26M-26,975.00%-2.15M--154K
Net cash flow
Beginning cash position -3.82%190.34M554.30%197.9M110.93%317.86M50.80%265.63M849.71%295.46M554.30%197.9M-70.09%30.25M333.84%150.7M222.06%176.15M--31.11M
Current changes in cash -90.24%9.52M-104.51%-7.57M-370.16%-127.53M305.17%52.23M-120.57%-29.83M11,178.96%97.56M336.52%167.65M1,151.57%47.21M-27.54%-25.46M--145.04M
End cash Position -32.36%199.85M-3.82%190.34M-3.82%190.34M110.93%317.86M50.80%265.63M849.71%295.46M554.30%197.9M554.30%197.9M333.84%150.7M--176.15M
Free cash flow -31.50%-39.21M-250.70%-112.73M-20.41%-27.76M-6.02%-24.71M-121.01%-30.45M-25.72%-29.82M185.72%74.81M-11.51%-23.06M-16.72%-23.31M--144.89M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +27.77%
Sample Name
Sample Code
 +22.86%
Sample Name
Sample Code
 -12.23%
4
United States Gasoline Fund Lp
UGA
-12.31%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
-12.65%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +16.44%
Sample Name
Sample Code
 +10.22%
Sample Name
Sample Code
 +9.75%
4
Amer Sports
AS
+3.46%
5
Zai Lab
ZLAB
+3.06%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On June 18, 2026, U.S. President Trump announced that a U.S.-Iran memorandum of understanding had been signed at the Palace of Versailles, w Show More
美伊和平曙光初現！全球市場「拆彈式狂歡」：誰在帶頭衝鋒，升势還能跑多遠？
After the U.S.-Iran memorandum of understanding, crude oil dropped 5%, and my first instinct was to check calls on airline stocks

- No more -